Poseida Therapeutics, Inc. (PSTX)

NASDAQ: PSTX · IEX Real-Time Price · USD

3.060

-0.170 (-5.26%)

At close: Jul 19, 2024, 4:00 PM

3.020

-0.040 (-1.31%)

Pre-market: Jul 22, 2024, 8:00 AM EDT

Poseida Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-108.86	-123.43	-64	-124.97	-129.78	-86.53	Upgrade
Depreciation & Amortization	5.67	5.61	5.17	4.55	2.59	1.19	Upgrade
Share-Based Compensation	21.04	23.13	18.93	16.7	7.22	3.05	Upgrade
Other Operating Activities	12.85	2.52	13.13	1.18	6.64	17.77	Upgrade
Operating Cash Flow	-69.3	-92.17	-26.77	-102.54	-113.33	-64.52	Upgrade
Capital Expenditures	-2.41	-3.07	-3.91	-2.62	-16.91	-5.16	Upgrade
Change in Investments	69.96	42.2	-199.42	225	-187.52	-37.31	Upgrade
Investing Cash Flow	67.55	39.13	-203.33	222.38	-204.43	-42.46	Upgrade
Share Issuance / Repurchase	14.42	15.35	75.3	0	310.11	149.78	Upgrade
Debt Issued / Paid	0	0	28.55	0	-0.33	9.95	Upgrade
Other Financing Activities	0.48	0.78	1.31	2.52	4.16	4.64	Upgrade
Financing Cash Flow	14.9	16.13	105.16	2.52	313.94	164.37	Upgrade
Net Cash Flow	13.15	-36.91	-124.95	122.36	-3.82	57.39	Upgrade
Free Cash Flow	-71.71	-95.23	-30.68	-105.16	-130.24	-69.67	Upgrade
Free Cash Flow Margin	-86.92%	-147.18%	-23.51%	-336.64%	-	-	Upgrade
Free Cash Flow Per Share	-0.75	-1.06	-0.43	-1.69	-3.62	-5.52	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).